Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination.
J Korean Med Sci
; 38(2): e12, 2023 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2198645
ABSTRACT
During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced hyperglycemia and related complications have been reported. However, there have been few reports of type 1 diabetes triggered by COVID-19 vaccines in subjects without diabetes. Here, we report the case of a 56-year-old female patient who developed hyperglycemia after the second dose of COVID-19 mRNA-based vaccination without a prior history of diabetes. She visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment. To our knowledge, this is the first case of the development of type 1 diabetes without diabetic ketoacidosis after mRNA-based COVID-19 vaccination, and is the oldest case of type 1 diabetes development under such circumstances.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus Tipo 1
/
Diabetes Mellitus Tipo 2
/
Vacunas contra la COVID-19
/
COVID-19
/
Hiperglucemia
Tipo de estudio:
Reporte de caso
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
/
Vacunas
Límite:
Adulto
/
Femenino
/
Humanos
/
Middle aged
Idioma:
Inglés
Revista:
J Korean Med Sci
Asunto de la revista:
Medicina
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS